Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07666087

Pilot Usability Study to Set Up and Use the Feetsee™ Foot Monitoring Device in Adults With Diabetes

Single-center, prospective, minimal-risk, non-experimental usability study assessing the setup and use of the FDA-registered (Class I medical device; 510(k)-exempt) Feetsee™ home foot-monitoring system by adults with diabetes in their home environment over 8 weeks.

This study in non clinical, observational pilot usability study conducted under FDA Human Factors and Usability Engineering guidance (2016).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

UT Health San Antonio

San Antonio, Texas, 78229, United States

Location contact

Lawrence A. Lavery, MD

PRINCIPAL_INVESTIGATOR

Nick Lucio

CONTACT

[email protected]

210-567-5142

About this study

Participants will be recruited from outpatient diabetes and podiatry clinics at UT Health San Antonio, an academic medical center. The study itself is conducted as a home-use usability study: after initial training, participants set up and use the Feetsee foot-monitoring system in their own homes, following the US IFU and in-app instructions. Data will be collected via paper/electronic CRFs, patient questionnaires, and Feetsee device/app usage logs (exported to REDCap and secure sponsor databases).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males and females aged 18 years or older
  • Clinical diagnosis of Type 1 or Type 2 diabetes
  • At least one palpable foot pulse per feet
  • Possess basic ability to use a smartphone or tablet
  • Have no prior experience with the Feetsee™ system
  • Be willing and able to provide informed consent

Exclusion criteria

  • Active foot ulceration at enrollment
  • Active Charcot neuro-osteoarthropathy
  • Severe vascular disease (complete absence of foot pulses)
  • Amputation of more than three toes
  • Active malignancy or immunosuppressive condition
  • Cognitive or physical impairments preventing proper device usage
  • Concurrent participation in another investigational study with contraindicated procedures

Treatment and study plan

Pilot Usability Study to Set Up and Use the Feetsee™ Foot Monitoring Device

Device

: after initial training, participants set up and use the Feetsee foot-monitoring system in their own homes, following the US IFU and in-app instructions. Data will be collected via paper/electronic CRFs, patient questionnaires, and Feetsee device/app usage logs (exported to REDCap and secure sponsor databases).

Primary outcomes

  1. Usability of the Feetsee Foot Monitoring System

    Time frame: 8 weeks

    • To evaluate the usability of the Feetsee Foot Monitoring System by both patients and healthcare providers when they use only the provided labeling, Quick Start Guide, Instructions for Use (IFU), and in-app instructions

Study contacts

Contact information is provided by the study sponsor or research team.

Helena Grinberg, PhD

CONTACT

[email protected]

+31615636666

Rytis Zajančkauskas, MD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Diabetis JSC

Industry

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jun 24, 2026
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.